PROVIROMICS Trademark

Trademark Overview


On Tuesday, January 25, 2022, a trademark application was filed for PROVIROMICS with the United States Patent and Trademark Office. The USPTO has given the PROVIROMICS trademark a serial number of 97237382. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 28, 2024. This trademark is owned by Retroviral Therapeutics LLC. The PROVIROMICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Vaccines; Biological preparations for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Medical preparations for the treatment of diseases, disorders and illnesses, namely, infectious diseases, cancer, osteporosis, kidney diseases, liver diseases, viral infections, and for use in oncology and retroviruses; Pharmaceutical preparations for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Therapeutic pharmaceuticals for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Therapeutic vaccines

Scientific and technological services, namely, testing in the field of viruses used for clinical and treatment purposes in the nature of virus testing for medical diagnostic or treatment purposes

Bacteriological research and analysis; Bacteriological research and testing; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials involving viruses used for clinical and treatment purposes; Consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific and technological services, namely, design, engineering, research, development and testing in the field of immunopharmaceuticals and vaccines involving viruses used for clinical and treatment purposes
proviromics

General Information


Serial Number97237382
Word MarkPROVIROMICS
Filing DateTuesday, January 25, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements


Goods and ServicesVaccines; Biological preparations for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Medical preparations for the treatment of diseases, disorders and illnesses, namely, infectious diseases, cancer, osteporosis, kidney diseases, liver diseases, viral infections, and for use in oncology and retroviruses; Pharmaceutical preparations for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Therapeutic pharmaceuticals for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Therapeutic vaccines
Goods and ServicesScientific and technological services, namely, testing in the field of viruses used for clinical and treatment purposes in the nature of virus testing for medical diagnostic or treatment purposes
Goods and ServicesBacteriological research and analysis; Bacteriological research and testing; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials involving viruses used for clinical and treatment purposes; Consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific and technological services, namely, design, engineering, research, development and testing in the field of immunopharmaceuticals and vaccines involving viruses used for clinical and treatment purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 31, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 31, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 14, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRetroviral Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLincoln, MA 01773

Party NameRetroviral Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLincoln, MA 01773

Trademark Events


Event DateEvent Description
Friday, January 28, 2022NEW APPLICATION ENTERED
Monday, January 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 24, 2022ASSIGNED TO EXAMINER
Tuesday, June 14, 2022NON-FINAL ACTION WRITTEN
Tuesday, June 14, 2022NON-FINAL ACTION E-MAILED
Tuesday, June 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 16, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, December 16, 2022EXAMINERS AMENDMENT E-MAILED
Friday, December 16, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 16, 2022EXAMINER'S AMENDMENT ENTERED
Friday, December 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 20, 2023ASSIGNED TO EXAMINER
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 19, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 19, 2023SOU EXTENSION 1 FILED
Tuesday, September 19, 2023SOU EXTENSION 1 GRANTED
Thursday, September 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 20, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 20, 2024SOU EXTENSION 2 FILED
Wednesday, March 20, 2024SOU EXTENSION 2 GRANTED
Thursday, March 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, October 28, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED